Constantine S. Tam
Fitzroy, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 344 publications
Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States.
Journal: Future oncology (London, England)
Published: July 30, 2026
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.
Journal: British journal of haematology
Published: June 20, 2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
Journal: British journal of haematology
Published: May 28, 2026
Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: May 06, 2026
Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-Up.
Journal: Advances in therapy
Published: April 01, 2026
The APLC expert consensus recommendations on the management of chronic lymphocytic leukaemia in Asia.
Journal: Annals of the Academy of Medicine, Singapore
Published: April 01, 2026
Richter transformation: emerging immunologic strategies beyond chemoimmunotherapy.
Journal: Blood advances
Published: March 11, 2026
Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 10, 2026
Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study.
Journal: British journal of haematology
Published: February 25, 2026
A Critical Review of Clinical Factors and Tools for Predicting Chimeric Antigen Receptor T-Cell Toxicities.
Journal: Transplantation and cellular therapy
Published: February 22, 2026
Last Updated: 09/26/2026